Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 9/20 | 0.70 |
| ▸ | CD74 | P04233 | 5/20 | 0.70 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | TP53 | P04637 | 3/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | IDO1 | P14902 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18805704 | 0.87 | MIF (0.81) | MIFCD74POLBMEN1KMT2A | |
| SCHEMBL2757838 | 0.82 | IDO1 (0.81) | MIFCD74MAPTPOLBMEN1 | |
| SCHEMBL13086455 | 0.82 | MIF (1.00) | MIFCD74POLBMEN1KMT2A | |
| SCHEMBL29566285 | 0.82 | MIF (1.00) | MIFCD74POLBMEN1KMT2A | |
| SCHEMBL2757836 | 0.82 | MIF (1.00) | MIFCD74POLBMEN1KMT2A | |
| SCHEMBL18805703 | 0.81 | MIF (1.00) | MIFCD74MAPTPOLBMEN1 | |
| SCHEMBL2757832 | 0.81 | MIF (0.70) | MIFCD74POLBMEN1KMT2A | |
| SCHEMBL16554239 | 0.80 | MIF (0.70) | MIFCD74MAPTTP53POLB | |
| SCHEMBL3270711 | 0.80 | MIF (1.00) | MIFCD74POLBMEN1KMT2A | |
| SCHEMBL2544424 | 0.78 | MAPT (0.49) | MIFCD74MAPTTP53POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11584717-B2 | MIF modulators | YALE UNIVERSITY (US) | 2023-02-21 | — | — | US | disclosed |
| US-20220143128-A1 | METHODS FOR TREATING TRAUMATIC BRAIN INJURY | BCELL SOLUTIONS, INC. (US) | 2022-05-12 | — | — | US | disclosed |
| US-20200377457-A1 | MIF MODULATORS | UNIV YALE (US) | 2020-12-03 | — | — | US | disclosed |
| US-20190270706-A1 | MIF MODULATORS | UNIV YALE (US) | 2019-09-05 | — | — | US | disclosed |
| US-10202343-B2 | MIF modulators | YALE UNIVERSITY (US) | 2019-02-12 | — | — | US | disclosed |
| US-20180162813-A1 | MIF MODULATORS | YALE UNIVERSITY | 2018-06-14 | — | — | US | disclosed |
| US-9643922-B2 | MIF modulators | YALE UNIVERSITY (US) | 2017-05-09 | — | — | US | disclosed |
| US-9643922-B2 | MIF modulators | YALE UNIVERSITY (US) | 2017-05-09 | — | — | US | disclosed |
| US-9540322-B2 | MIF modulators | YALE UNIVERSITY (US) | 2017-01-10 | — | — | US | disclosed |
| US-20120004261-A1 | MIF MODULATORS | YALE UNIVERSITY (US) | 2012-01-05 | — | — | US | disclosed |
| US-20100267714-A1 | MIF MODULATORS | YALE UNIVERSITY | 2010-10-21 | — | — | US | disclosed |
| US-20100267714-A1 | MIF MODULATORS | YALE UNIVERSITY | 2010-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11584717-B2 | MIF modulators | MIF, HMGB2, HMGB3 | MIF 1/4885CD74 15/4885MAPT 3356/4885 |
| US-20200377457-A1 | MIF MODULATORS | MIF, HMGB2, HMGB3 | MIF 1/4885CD74 15/4885MAPT 3356/4885 |
| US-20180162813-A1 | MIF MODULATORS | MIF, HMGB2, HMGB3 | MIF 1/4885CD74 15/4885MAPT 3356/4885 |
| US-20220143128-A1 | METHODS FOR TREATING TRAUMATIC BRAIN INJURY | CD74, MIF, MICA | MIF 2/4885CD74 1/4885MAPT 2168/4885 |
| US-20120004261-A1 | MIF MODULATORS | MIF, HMGB2, HMGB3 | MIF 1/4885CD74 15/4885MAPT 3356/4885 |
| US-20100267714-A1 | MIF MODULATORS | MIF, HMGB2, HMGB3 | MIF 1/4885CD74 15/4885MAPT 3356/4885 |
| US-10202343-B2 | MIF modulators | MIF, HMGB2, HMGB3 | MIF 1/4885CD74 15/4885MAPT 3356/4885 |
| US-20190270706-A1 | MIF MODULATORS | MIF, HMGB2, HMGB3 | MIF 1/4885CD74 15/4885MAPT 3356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.